DT120

DRUG4 trials

Sponsors

Definium Therapeutics US, Inc.

Conditions

Generalized Anxiety DisorderMajor Depressive Disorder

Phase 3

A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)

Active, not recruitingNCT06741228

Definium Therapeutics US, Inc.Generalized Anxiety Disorder

Start: 2024-12-11End: 2026-11-01Updated: 2026-09-02

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

Active, not recruitingNCT06809595

Definium Therapeutics US, Inc.Generalized Anxiety Disorder

Start: 2025-01-29End: 2027-05-01Updated: 2026-09-04

A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

Active, not recruitingNCT06941844

Definium Therapeutics US, Inc.Major Depressive Disorder

Start: 2025-04-14End: 2027-02-01Updated: 2026-08-28

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

RecruitingNCT07592689

Definium Therapeutics US, Inc.Major Depressive Disorder

Start: 2026-05-10End: 2028-06-01Target: 165Updated: 2026-08-10